Cogprints

Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment

Shirayama, Takeshi (2003) Role of Atrial Fibrillation Threshold Evaluation on Guiding Treatment. [Journal (Paginated)]

Full text available as:

[img]HTML
43Kb

Abstract

Atrial fibrillation could be induced reproducibly by 50Hz rapid stimulation which was given through systolic and early diastolic phase of atrial excitation. Duration of atrial fibrillation induced in this way was roughly dependent on the current amplitude of the stimulation. The minimum current that could induce long-lasting atrial fibrillation (30sec in the clinical setting, 2sec in the rabbit or rat model) was defined as atrial fibrillation threshold (AFT). AFT was larger in patients who had history of atrial fibrillation than those who did not. Anti-arrhythmic drugs raised AFT by various degrees both in experimental and clinical cases. Long-term efficacy of a drug could be predicted in a patient, measuring how much the drug increased AFT (cut-off point = 5mA increase). AFT is a useful marker to evaluate atrial vulnerability and to guide pharmacological treatment of atrial fibrillation.

Item Type:Journal (Paginated)
Keywords:atrial fibrillation, electrophysiological test, therapy, prognosis
Subjects:JOURNALS > Indian Pacing and Electrophysiology Journal
ID Code:4248
Deposited By:Indian Pacing and Electrophysiology, Journal
Deposited On:20 Apr 2005
Last Modified:11 Mar 2011 08:55

References in Article

Select the SEEK icon to attempt to find the referenced article. If it does not appear to be in cogprints you will be forwarded to the paracite service. Poorly formated references will probably not work.

1. Khairy P, Nattel S. New insights into the mechanisms and management of atrial fibrillation. CMAJ 2002;167(9):1012-1020.

2. Bosch RF, Nattel S. Cellular electrophysiology of atrial fibrillation. Cardiovasc Res 2002;54(2):259-269.

3. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation--very new insights into very old ideas. Annu Rev Physiol 2000;62:51-77.

4. Wijffels MC, Crijns HJ. Non-invasive characteristics of atrial fibrillation: the value of Holter recordings for the treatment of AF. Card Electrophysiol Rev 2002;6(3):233-238.

5. Brundel BJ, Henning RH, Kampinga HH, Van Gelder IC, Crijns HJ. Molecular mechanisms of remodeling in human atrial fibrillation. Cardiovasc Res 2002;54(2):315-324.

6. Gaspo R. The tachycardia-induced dog model of atrial fibrillation. Clinical relevance and comparison with other models. J Pharmacol Toxicol Methods 1999;42(1):11-20.

7. Inoue M, Inoue D, Ishibashi K, Sakai R, Shirayama T, Asayama J, Nakagawa M. Effects of E-4031 on atrial fibrillation threshold in guinea pig atria: comparative study with class I antiarrhythmic drugs. J Cardiovasc Pharmacol 1994;24(4):534-541.

8. Inoue M, Inoue D, Ishibashi K, Sakai R, Omori I, Yamahara Y, Asayama J, Nakagawa M. Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide. Jpn Heart J 1993;34(3):301-312.

9. Matsuo R, Shirayama T, Inoue K, Matoba Y, Imai H, Shiraishi H, Tatsumi T, Nakagawa M. SD3212, a new antiarrhythmic drug, raises atrial fibrillation threshold in isolated rabbit hearts. Heart Vessels 1999;14(3):127-136.

10. Shirayama T, Sakamoto T, Yamamura M, Yoshida A, Mani H, Sakatani T, Matoba Y, Imai H, Nakagawa M. Mechanism of shortening of atrial refractory period after short term rapid pacing. Clinical Cardiac Pacing and Electrophysiology. edited by H-F Tse, KL Lee and CP Lau. Bologna:Monduzzi Editore. 2003:467-470.

11. Ishibashi K, Inoue D, Sakai R, Inoue M, Shirayama T, Asayama J, Nakagawa M. Effects of disopyramide on the atrial fibrillation threshold in the human atrium. Int J Cardiol 1995;52(2):177-184.

12. Inoue K, Shirayama T, Shiraishi H, Matoba Y, Imai H, Inoue D, Nakagawa M. Clinical significance of the atrial fibrillation threshold in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2001;24(5):796-805.

13. Shirayama T, Shiraishi H, Yoshida S, Matoba Y, Imai H, Nakagawa M. Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease. Europace. 2002 ;4(4):383-389.

14. Sugimoto T, Schaal SF, Wallace AG. Factors determining vulnerability to ventricular fibrillation induced by 60cps alternating current. Circ Res 1967;21:601-608.

15. Toda I, Murakami Y, Nozaki A, Kawakubo K, Sugimoto T. Ventricular fibrillation threshold measured by continuous 50cps stimulation for the evaluation of the antifibrillatory effect of the drugs. Jpn Circ J 1988;52:249-253.

16. Kostis JB, Goodking MJ, Gotzoyannis S, et al. Effect of lidocaine on the atrial fibrillation threshold. Am Heart J 1977;94:764-768.

17. Wiggers CJ, Wégria R: Ventricular fibrillation due to single, localized induction and condensor shocks applied during the vulnerable phase of ventricula systole. Am J Physiol 1940;128: 500-505

18. Wiggers CJ, Wégria R: Quantitative measurement of fibrillation threshold of mammalian ventricles with observations on the effect of procaine. Am J Physiol 1940;131: 296-308.

19. Karagueuzian HS, Chen PS. Cellular mechanism of reentry induced by a strong electrical stimulus: implications for fibrillation and defibrillation. Cardiovasc Res 2001;50(2):251-262.

20. Chen PS, Feld GK, Kriett JM, Mower MM, Tarazi RY, Fleck RP, Swerdlow CD, Gang ES, Kass RM. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993;88(1):186-192.

21. Michelson EL, Spear JF, Neil Moore E. Effects of procainamide on strength-interval relations in normal and chronically infarcted canine myocardium. Am J Cardiol 1981:47(6),1223-1232.

22. Orias O, Gilbert JL, Siebens AA, Suckling EE, McC Brooks C. Effectiveness of single rectangular electrical pulses of known duration and strength in evoking auricular fibrillation. Am J Physiol 1950; 162: 219-225.

23. McC Brooks C, Orias O, Gilbert JL, Siebens AA, Hoffman BF, Suckling EE. Auricular fibrillation: relationship of ‘vulnerable period’ to ‘dip’ phenomenon of auricular excitability curve. Am J Physiol 1951;164: 301-306.

24. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S. Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107(10):1440-1446.

25. Kanki H, Mitamura H, Takatsuki S, Sueyoshi K, Shinagawa K, Sato T, Ogawa S. Postrepolarization refractoriness as a potential anti-atrial fibrillation mechanism of pilsicainide, a pure sodium channel blocker with slow recovery kinetics. Cardiovasc Drugs Ther 1998;12(5):475-482.

26. Wettwer E, Scholtysik G, Schaad A, Himmel H, Ravens U. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol 1991;17(3):480-487.

27. Ohler A, Amos GJ, Wettwer E, Ravens U. Frequency-dependent effects of E-4031, almokalant, dofetilide and tedisamil on action potential duration: no evidence for "reverse use dependent" block. Naunyn Schmiedebergs Arch Pharmacol 1994;349(6):602-610.

28. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation 1995;92(7):1954-1968.

29. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54(2):230-246.

30. Yamashita T, Murakawa Y, Hayami N, Fukui E, Kasaoka Y, Inoue M, Omata M. Short-term effects of rapid pacing on mRNA level of voltage-dependent K(+) channels in rat atrium: electrical remodeling in paroxysmal atrial tachycardia. Circulation 2000;101(16):2007-2014.

31. Ohe T, Matsuhisa M, Kamakura S, Yamada J, Sato I, Nakajima K, Shimomura K. Relation between the widening of the fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983;52(10):1219-1222.

32. Mason JW. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med 1993;329(7):452-458.

33. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347(23):1825-1833.

Metadata

Repository Staff Only: item control page